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Abstract
Background: In highly copy number variable (CNV) regions such as the human defensin gene locus,
comprehensive assessment of sequence variations is challenging. PCR approaches are practically restricted to tiny
fractions, and next-generation sequencing (NGS) approaches of whole individual genomes e.g. by the 1000
Genomes Project is confined by an affordable sequence depth. Combining target enrichment with NGS may
represent a feasible approach.
Results: As a proof of principle, we enriched a ~850 kb section comprising the CNV defensin gene cluster DEFB,
the invariable DEFA part and 11 control regions from two genomes by sequence capture and sequenced it by 454
technology. 6,651 differences to the human reference genome were found. Comparison to HapMap genotypes
revealed sensitivities and specificities in the range of 94% to 99% for the identification of variations.
Using error probabilities for rigorous filtering revealed 2,886 unique single nucleotide variations (SNVs) including
358 putative novel ones. DEFB CN determinations by haplotype ratios were in agreement with alternative methods.
Conclusion: Although currently labor extensive and having high costs, target enriched NGS provides a powerful
tool for the comprehensive assessment of SNVs in highly polymorphic CNV regions of individual genomes.
Furthermore, it reveals considerable amounts of putative novel variations and simultaneously allows CN estimation.
Background
The defensin gene locus at chromosome 8p23.1 is one
of the most copy number (CN) variable regions of the
human genome [1]. It harbors genes for different alpha-
and ß-defensins, antimicrobial and cytotoxic peptides
involved in the orchestrated defense of infection and
cancer [2,3]. Both gene dosage (CN) and sequence varia-
tion (SNP) affect expression and may influence physiolo-
gical and pathogenic processes. Hence, determining both
types of variants is a prerequisite to further correlate
genetic architecture and phenotype [4].
For such targets, assessment of SNPs and multisite
variations (MSVs) - comprehensively called single
nucleotide variations (SNVs) - simultaneously with reli-
able CN estimation is extraordinarily challenging. PCR
based SNV assessment combined with CN estimation
both by traditional Sanger and next-generation sequen-
cing (NGS) is feasible [5-7] but covers only tiny parts of
the region consisting of two clusters (DEFA and DEFB)
spanning ~200 and ~235 kb, respectively.
Recently, NGS methods have allowed re-sequencing of
complete individual human genomes [8-13]. On the
other hand, costs are still too high for sequencing entire
genomes when only CNV regions of several hundred kb
are of interest.
A way to overcome this constriction may be sequence
capture methods allowing the enrichment of selected tar-
get regions over 1000-fold above their normal fraction in
the genome [14,15]. These techniques are either based
on arrays [16-20] or in-solution enrichments [21,22].
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the sequence variability in the 8p23 DEF region of
human genomes with simultaneous estimation of DEFB
cluster CNs, we enriched the DEF regions and 11 differ-
ent bona fide single copy control regions (CTRL) from
two cell-line derived individual DNAs by NimbleGen
Sequence Capture Arrays and sequenced by 454/Roche.
The 454/Roche technology was chosen as it provides
the longest sequence reads among available NGS
approaches which in turn allowed inference of CNs
from haplotype ratios [6] simultaneously with the varia-
bility assessment.
Methods
To investigate a “simple” as well as a “complex” case in
terms of DEFB sequence variability we selected the sam-
ples NA12716 and NA12760, harboring 2 and 6 DEFB
copies per diploid genome, respectively, as multiply
determined by different methods [7,23-25]. Both gen-
omes were genotyped by the International HapMap pro-
ject [26], the corresponding cell lines were derived from
male individuals of European origin and are publicly
available. Next generation sequencing of these DNA
samples was done in the framework of the 1000 Gen-
omes Project (http://www.1000genomes.org/) in the low
coverage group by the Solexa/Illumina and ABI/SOLiD
platforms resulting in 24 Gb (NA12716) and 40 Gb
(NA12760) raw data, respectively.
Cell lines and DNAs
B-lymphocyte, EBV transformed cell lines GM12716
(CEPH Utah pedigree 1358, male, European origin) and
GM12760 (CEPH Utah pedigree 1447, male, European
origin) were purchased from the Coriell cell depository
(http://ccr.coriell.org/). Both cell lines are part of the
HapMap project HAPMAPPT01 (http://hapmap.ncbi.
nlm.nih.gov/). Cell lines were cultured in RPMI1640
with GIBCO GlutaMAX™ (Invitrogen) with 10% Fetal
Bovine Serum “GOLD” (PAA Laboratories, Austria) and
1.5% PenStrep (Roth, Karlsruhe, Germany) in 25 mL
and 75 mL BD Falcon™ flasks at 37°C and 5% CO2 in a
total amount of 10 mL and 30 mL, respectively. Cells
were grown to a density of 1 × 10
6 cells/mL and split in
a ratio of 1:3. From the cell lines, DNAs NA12716 and
NA12760 were isolated using the QIAamp DNA-Blood
Mini Kit (Qiagen, Germany).
Sequence Capture Enrichments
Total amounts of 32 ug of DNA NA12716 (c = 265 ng/
uL in TE) and 30 ug of DNA NA12760 (c = 150 ng/uL
in TE), both with A
260/A
280 ≥1.8 and A
260/A
230≥1.9
(measured by Nanodrop) were enriched using a custo-
mer designed 385K 1-plex sequence capture array fol-
lowing the manufacturer’s instructions (Roche
NimbleGen, Madison, WI). Target regions, captured
regions and chromosomal positions are listed in addi-
tional file 1.
Target Enrichment
DNA was isolated from the cell lines and enriched on a
customized 385K Sequence Capture Array, designed and
produced by NimbleGen (Madison, WI, USA). On the
array, 694 kb (82%) of the 850 kb target comprised by
DEFA (195 kb), DEFB (234 kb) and 11 CTRL regions
(421 kb) were tiled by probes (additional file 1). Within
two of these CTRL genes (ANGPT2, MFHAS1), probe
hybridization sites were previously defined for Multiplex
Ligation Dependent Probe Amplification (MLPA) and
used for calibration of DEFB CN estimation [27].
454 Sequencing
Shotgun sequencing libraries were prepared by the GS
Titanium library preparation kit following the manufac-
turer’s instructions (Roche Diagnostics). The single-
stranded libraries were quantified by a qPCR assay [28]
and processed utilizing the GS Titanium emPCR and
XLR70t sequencing kit (Roche Diagnostics) according to
the manufacturer’s instructions. Sequencing was per-
formed by three runs on a half 70 × 75 picotiter plate
each (NA12716) and one run on a complete 70 × 75
picotiter plate (NA12760), respectively. Sequencing of
the enriched DNA by GS FLX (Titanium, Roche) yielded
~450 Mb (NA12716) and ~300 Mb (NA12760) of raw
sequence data. The raw sequence data outputs (reads,
bp, average read lengths) are listed in additional file 2.
All 454 sequences mapping to the CTRL, DEFA and
DEFB target regions were deposited at the NCBI Short
Read Archive (SRA, http://www.ncbi.nlm.nih.gov/
Traces/home/) under the accession number SRA024359.
Sequence Analysis
The 454 reads in the sff files from NA12716 and
NA12760 were independently mapped by the GS Refer-
ence Mapper against the concatenated target regions as
backbone with a minimum initial match of 92% and a
minimal initial mapping length of 80 bp (target filter-
ing). The fully and uniquely mapping sequences were
then mapped again to the human genome (NCBI build
36, hg18) masked for all except the target regions (chro-
mosomal filtering). To distinguish between known and
putative novel SNVs the information about known SNP
positions for the reference sequence (GoldenPath
snp128.txt) were used. The SNVs classified as putative
novel by these information were re-validated by align-
ment against the human reference SNP sequence data
(ftp://ftp.ncbi.nih.gov/snp/organisms/human_9606/
rs_fasta/) using Blat [29]. The Blat output was analyzed
by an inhouse perl script.
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Sequencing errors that accumulate at particular posi-
tions may falsely indicate novel alleles. HapMap SNPs
homozygous for the variant allele of the CTRL and
DEFA regions (n = 248) were used to determine the
average per-site error frequency in the aligned reads as
2.3%. A binomial distribution was then used to model
the false positive rate in SNP/SNV detection, given the
average error frequency (p) and local sequencing depth
(n). The model was used to evaluate all putative allele
calls reported by HCDiff by calculating the posterior
probability of observing d identical deviations just as a
result of error: p(k  d) =
 N
d
B(k—n, p).At h r e s h o l d
of P = 10
-3 was applied to remove likely false positives
from the output of HCDiff.
SNV verification by PCR/cloning/Sanger sequencing
SNV verification was performed using the cell line
derived DNA without sequence capture enrichment.
PCR primers are listed in additional file 3. PCR products
were either directly sequenced using dye terminator
chemistry (ABI3730xl) or after cloning into pCR2.1
TOPO vector (Invitrogen).
Haplotyping and CN estimations
For haplotyping, all sequences covering the haplotyping
candidate regions (HTCR) were extracted and re-
assembled in GAP4 (Staden package). The GAP4 assem-
blies were manually inspected at the polymorphic posi-
tions and haplotypes were inferred by a proprietary
script. CN estimations were done as previously
described [5-7] by counting all sequences representing
the same haplotype and calculating the ratio of read
numbers.
Results
Identification of high confidence differences (HCDiff)
The raw data obtained from 454 sequencing of the tar-
g e te n r i c h e dD N A( s e eM e t h o d s )w e r es u b j e c t e dt oa n
analysis and filter process depicted in Figure 1. A first
filtering was done by mapping the raw data against the
target regions. The fractions of fully and uniquely map-
ping reads were 47% and 51% for NA12716 and
NA12760 and 91% and 93% of the target regions were
covered by at least 2 sequences, respectively. In relation
to 850 kb target and 3 Gb human genome, the enrich-
ment rates were ~470x and ~630x. The corresponding
sequencing depths for CTRL, DEFA, and DEFB were
Figure 1 Workflow for the identification of SNVs from 454 sequences generated after target enrichment by NimbleGen sequence
capture of individual DNAs.
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Page 3 of 1360x, 56x, 45x for NA12716 and 44x, 37x, 100x for
NA12760, respectively. The target filtered sequences
were then mapped by the Reference Mapper (Roche)
against the human genome (NCBI build 36.1, UCSC
hg18) in order to assign chromosomal positions and to
provide high confidence differences (HCDiffs) to the
reference. These differences included single nucleotide
variations (SNVs), insertions/deletions (indels) and com-
plex nucleotide exchanges. We further focused on SNVs
by discarding indels and complex exchanges from the
HCDiffs list. This resulted in 3,161 and 3,490 HCDiffs
for the CTRL, DEFA and DEFB regions of NA12716
and NA12760, respectively.
Evaluation of sensitivity, specificity and false discovery
rate by comparison to HapMap SNPs
To estimate the accuracy of the SNV identification and
to define reliable quality filter settings for the DEFB ana-
lyses, we compared the HCDiff data of the single-copy
CTRL and DEFA regions with SNP data from the Inter-
national HapMap project (http://hapmap.ncbi.nlm.nih.
gov). We categorized the 1,388 and 1,251 HCDiffs for
NA12716 and NA12760, respectively, by their variant’s
allele frequencies (VAF, frequency of the allele deviating
from the hg18 reference). According to the Reference
Mapper software, VAFs for HCDiffs by definition range
between 10% and 100%. We therefore defined the cate-
gories as homozygous for the reference allele (10%
≤VAF <25%), heterozygous (25% ≤VAF ≤75%) and
homozygous for the variant (75% <VAF ≤100%) (addi-
tional file 4). The corresponding HapMap data (Phase
III, release 2, February 2009) for CTRL and DEFA of
NA12716 and NA12760, comprised 1,337 and 1,322
genotypes, respectively. Comparing the HapMap data
with our HCDiffs, we estimate that our approach has
equal sensitivity and specificity for the identification of
hetHCDiffs (94%-97%) and homvarHCDiffs (98%-99%)
for bona fide single-copy loci with 2 copies per diploid
genome (Table 1).
In addition, we characterized the false discovery rate in
more detail. It is caused by sequencing errors that accu-
mulate at particular positions and falsely indicate novel
alleles. Using 248 HapMap SNPs of the CTRL and DEFA
regions of NA12716 which are homozygous for the var-
iant allele we determined the average per-site error fre-
quency in the alignment as 2.3%. This rate reflects the
combined errors from sequencing and read mapping. A
binomial distribution was then used to model the false
Table 1 Comparison of high confidence differences (HCDiffs) obtained from the CTRL and DEFA regions by sequence
capture (SeqCap) with HapMap SNP genotypes.
NA12716 NA12760 NA12716 NA12760
HapMap: heterozygous 244 263 SeqCap: heterozygous 711 646
SeqCap: HapMap:
homozygous for reference, no HCDiff 0 5 heterozygous 237 248
homozygous for reference 0 2 homozygous for variant 5 4
heterozygous 237 248 homozygous for reference 10 4
homozygous for variant 3 0
not or poorly covered/alignment problem 4 8
HapMap: homozygous for variant 254 217 SeqCap: homozygous for variant 526 468
SeqCap: HapMap:
homozygous for reference, no HCDiff 0 0 homozygous for variant 248 212
homozygous for reference 0 0 homozygous for reference 0 0
heterozygous 5 4 heterozygous 3 0
homozygous for variant 248 212
not or poorly covered/alignment problem 1 1
HapMap: homozygous for reference 839 842 SeqCap: homozygous for reference 151 137
SeqCap: HapMap:
homozygous for reference, no HCDiff 827 835 homozygous for variant 0 0
homozygous for reference 1 1 homozygous for reference 1 1
heterozygous 10 4 heterozygous 0 2
homozygous for variant 0 0
not or poorly covered/alignment problem 1 2
Sensitivity (heterozygous) 97,1% 94,3% Specificity (heterozygous) 94,0% 96,9%
Sensitivity (homozygous) 98,4% 99,0% Specificity (homozygous) 98,4% 98,6%
The SeqCap HCDiffs were categorized according to the variant’s allele frequency (VAF) with the human genome sequence (hg18) as reference allele: homozygous
for reference (VAF 10-24%); heterozygous (VAF 25-75%); homozygous for variant (VAF 76-100%).
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Page 4 of 13positive rate in HCDiff detection, given the average error
frequency (p = 0.023) and local sequencing depth (n) (see
Materials and Methods). VAF distributions of sequenced
HapMap sites and VAF distributions predicted by this
binomial model showed good agreement (additional files
5, 6). Consequently, this model was used to assign the
posterior error probability P to each putative allele call
reported by HCDiff, and this was used for quality estima-
tion of HCDiffs (see below).
SNV assessment by filtering of HCDiffs
To obtain a reliable set of SNVs, the identified
HCDiffs were successively subjected to two filter steps.
First, by comparison to the hg18 reference, we re-
checked our target regions for parts with more para-
logs than annotated in the known copy number vari-
able DEFA and DEFB regions at 8p23.1. We identified
a 69 kb region in the DEFB cluster which overlaps an
8 0k bl o wc o p yr e p e a t( L C Rt y p eI V )[ 6 ] .L C RI Vh a s
additional paralogs at chromosomes 8 and 12. They
are subjected to the enrichment together with the tar-
get regions due to sequence identities of up to 98%
and hampered the SNV identification in the DEFB
region. Consequently, we excluded all variations identi-
fied in this region, reducing the data set to 1,965 and
2,369 HCDiffs for NA12716 and NA12760, respec-
tively, corresponding to 62% and 68% of the primary
amount (additional file 7).
Then, as a sequence quality filtering, we applied our
binomial distribution model (see above) to the reduced
set of HCDiffs. Variants with probability values P >1 ×
10
-3, were considered error-prone and discarded, finally
resulting in 1,919 and 2,265 HCDiffs (61% and 65%) for
NA12716 and NA12760, respectively (additional file 8).
When plotting the HCDiffs according to their VAFs,
the VAF distribution profile changes as a result of the
filter process. For NA12716, due to the copy number of
2 for all target regions, HCDiffs should be spread
around 50% VAF (heterozygous) and near 100% (homo-
zygous for the variant). However, with the unfiltered
HCDiffs, we observed a high amount of HCDiffs far
below the expected peak at 50% VAF. In contrast, the
plot of the filtered variations has exactly the anticipated
pattern. Analogously, the curve for NA12760 CTRL
+DEFA (2 copies) is changed after filtering, resulting in
a shape similar to NA12716 (additional file 9). For
NA12760 DEFB (6 copies) the diagram reflects the dif-
ferent VAFs from allele ratios of 1:5 to 6:0 (Figure 2).
We defined the set of 1,919 and 2,265 filtered HCDiffs
as the final set of SNVs which was sub-classified by
region and presence or absence from the SNP database
(known/putative novel SNV). To distinguish between
both categories we initially used the UCSC hg18 annota-
tions and re-validated the variations classified as
unknown by comparison to the more up-to-date
dbSNP130 database (release 2009, April 30
th). This
Figure 2 Distribution of variant’s allele frequencies (VAFs) before (HCDiffs) and after filtering (SNVs).
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CTRL regions, 604/27 in DEFA and 560/113 in DEFB of
NA12716. For NA12760, 595/48 SNVs in CTRL, 428/37
in DEFA and 979/178 in DEFB were identified.
Similarly to the HapMap comparison (see above) we
further classified the SNVs by VAF. For CTRL and
DEFA in both samples as well as for DEFB in NA12716,
SNVs with 25% ≤VAF ≤75% were regarded as heterozy-
gous (het) and as homozygous for the variant (homvar)
with 75% < VAF ≤100%. This revealed 1,165 het and
695 homvar SNVs (61% and 36% of all, respectively) for
NA12716 and 610 het (55%) and 468 homvar (42%) for
NA12760. For both samples, a fraction of ambiguous
SNVs with 10% ≤VAF <25% remained, encompassing
only ~3% of all SNVs, which can be regarded as mea-
sure of the false positive rate in the lower quarter of
VAF. The SNVs from NA12760 DEFB (6 copies per
diploid genome) were sub-classified by the number of
copies deviating from the hg18 reference using the VAF
ranges 10-24%/25-42%/43-58%/59-75%/76-92%/93-100%.
This revealed 507, 257, 156, 88, 59 and 89 SNVs for the
s i xc l a s s e sf r o m1o u to f6c o p i e st o6o u to f6c o p i e s
(homvar).
We also checked the final SNV sets for overlap
between both DNAs, resulting in 771 known/77 putative
novel unique SNVs in the CTRL regions, 701/61 in
DEFA and 1,056/220 in DEFB (Table 2). A summary for
the final SNV sets is shown in Figure 3, all HCDiffs and
SNVs are listed in detail in additional files 10, 11
and 12.
Experimental validation of SNV candidates
To test the reliability of SNV identification by our pipe-
line we experimentally verified 22 HCDiffs from the
CTRL, DEFA, and DEFB regions of NA12760. All inves-
t i g a t e dH C D i f f sa r ep u t a t i v en o v e lv a r i a t i o n s .T h es e t
comprised HCDiffs with sequencing depths ranging
from 17 to 120 reads and VAFs between 13% and 97%.
The SNV flanking regions were amplified from the
total non-enriched DNA NA12760 and the PCR pro-
ducts were sequenced by the Sanger method. Further-
more, 3 DEFA and 6 DEFB PCR products were also
subcloned and the clones were sequenced. For 19
HCDiffs with VAFs between 17% and 76%, the presence
of two alleles could be confirmed. For 2 HCDiffs with
96% and 97% VAF, respectively, the variant allele was
found exclusively. The remaining 1 HCDiff
(chr8:7,261,330) with a sequence depth of 104 and 13%
VAF was found homozygous for the hg18 reference
allele in the Sanger-sequenced PCR product as well as
in 98 clones derived from it. Hence, 21 HCDiffs out of
22 (95%) were confirmed. For the HCDiffs which were
additionally verified by cloning, the VAF values of clon-
ing and 454 sequencing are in good agreement (addi-
tional file 13).
Comparison of the HapMap with our NA12716 data
revealed 18 discrepancies which can be divided in three
groups: (A) heterozygous/homozygous for the variant
(HapMap/sequence capture; 3 cases); (B) homozygous
for the variant/heterozygous (5 cases) and (C) homozy-
gous for the reference/heterozygous (10 cases). We veri-
fied 14 of these variations by PCR and Sanger
sequencing, confirming for 9 and 5 the sequence capture
results or HapMap status, respectively. In addition to the
18 discrepancies, 6 HapMap SNVs were not resolved by
the sequence capture experiment due to low sequence
depth, low quality or alignment errors (Table 1).
Haplotyping and CN estimations
With an average read length of >300 bp, in regions of
high SNV densities at least a certain amount of GS FLX
sequences should span two or more SNVs positions,
allowing the inference of haplotypes. Furthermore, as
previously shown [5-7], copy numbers can be estimated
from the ratio of sequences representing the distinct
haplotypes.
For this purpose we have selected from our align-
ments 13 haplotyping candidate regions (HTCRs) within
DEFB of NA12716 and NA12760. Altogether, the
HTCRs harbor 165 SNVs and span 10 kb (~16 SNVs/
kb) with at least 9 SNVs/kb (additional files 14, 15). For
the inference of haplotypes from HTCRs we postulated
a minimal number of 5 sequences per haplotype. Conse-
quently, haplotyping was done if the SNV combination
was covered by ≥10 reads for NA12716 (2 copies per
diploid genome) and ≥30 reads for NA12760 (6 copies).
In total, 124 SNVs could be used to identify 188
Table 2 Known and putative novel (putnov) SNVs and SNV densities in CTRL, DEFA and DEFB of NA12716 and
NA12760 after successive filtering of HCDiffs
Total CTRL DEFA DEFB
SNVs SNVs per kb known putnov SNVs per kb known putnov SNVs per kb known putnov SNVs per kb
NA12716 1.919 2,3 574 41 1,5 604 27 3,2 560 113 4,1
NA12760 2.265 2,7 595 48 1,5 428 37 2,4 979 178 7,0
unique SNVs 2.886 771 77 701 61 1.056 220
848 762 1.276
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22; NA12760 166 haplotypes).
At the loci with 2 copies per diploid genome, the ratio
of reads representing the same haplotype should be 1:1.
Indeed, we found for NA12716 DEFB 11 SNV combina-
tions consisting of two haplotypes in a ratio of 172:173
reads (0.99:1). For NA12760 CTRL, 14 × 2 haplotypes
were inferred with a total read ratio of 104:97 (1.07:1;
additional file 16).
In the DEFB region of NA12760 (6 copies), 48 CN
estimations could be done from 166 different haplotypes
(on average 3.5 haplotypes per SNV combination),
revealing between 4 and 8 copies per diploid genome
with an average of 6.17 ± 1.06 (Table 3)
SNVs in the putative DEFB4 promoter region
Recently we have identified haplotypes in the putative
DEFB4 promoter region (hg18 chr8:7,261,867-7,263,764
and chr8:7,787,643-7,789,537) and have found an extra-
ordinarily high density of ~26 SNVs per kb [25]. We
therefore inspected the sequence alignments of
NA12716 and NA12760 in this region (SNVs 227 to
277; additional file 17). In total, 13 out of 42 SNVs iden-
tified by Groth et al. were also found to be heterozygous
or homozygous for the variant in NA12716. Analo-
gously, we identified 24 such positions in NA12760 of
which 12 are identical in both DNAs. Thus, for 25 out
of 42 SNV positions (60%) previously identified in 9
individuals, the variant alleles were also found in at least
one of the two genomes of NA12716 and NA12760
(Figure 4).
Two additional SNVs were found to be polymorphic in
NA12760. One (SNV252, putative novel) showed 10%
VAF, the second (SNV260, rs2737910) 27%VAF. In the
same way as described above we also inferred haplotypes
from the NA12760 putative DEFB4 promoter region
(additional file 18).
Discussion
CN polymorphisms are an experimental challenge with
respect to their identification as well as for their geno-
typing in association or linkage studies [30]. Disease
association analyses in CN variable loci are therefore
currently restricted to the determination of CNs thereby
often ignoring the variable sequence contents of the
respective copies. The defensin locus on 8p23 is an
extreme example of a large CN variable genomic locus
(235 kb, 2 to at least 12 copies in individual genomes).
Knowledge of the copies’ variability is still fragmentary
and we aimed with our study to describe it in more
detail. The power of a combination of selective enrich-
ment of target regions in the human genome and NGS
has already been demonstrated [17,31-33], but such an
approach has not been applied to CN variable loci so
far.
By our sequence capture experiments using two indi-
vidual genomic DNAs, the CTRL, DEFA and DEFB tar-
get regions with a total length of 850 Mb were enriched
600fold above their normal fraction in the whole human
genome. Since this calculation is related to the entire
target instead of the captured regions (82%), the enrich-
ment rate is rather underestimated and in every case
higher than determined by qPCR in the course of the
enrichment process (~150fold, data not shown). Subse-
quent 454 sequencing of the enriched DNAs and map-
ping the sequences to the human genome resulted in
CTRL, DEFA and DEFB sequence depths of 60, 56 and
45 (1.1:1.0:0.8) for NA12716 and 44, 37 and 100
Figure 3 Known and putative novel SNVs identified in the different target regions of NA12716 and NA12760.
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Page 7 of 13(1.1:0.9:2.5) for NA12760, respectively. Although the
sequencing depth ratios CTRL:DEFA:DEFB are not
exactly 1:1:1 for NA12716 and 1:1:3 for NA12760 as
expected from the DEFB CNs, the higher coverage of
DEFB in NA12760 compared to NA12716 reflects the
difference in DEFB CNs between the two DNAs and
saturation of the array in case of high target region
CNs. Furthermore, the CTRL:DEFA sequence depth
ratio of ~1:1 for both DNAs indicates the single copy
status (2 copies per diploid genome) of these regions.
Quality estimation and filtering
Assessment of known and putative novel single nucleo-
tide variants (SNVs) was performed on the base of the
Roche Reference Mapper software providing high confi-
dence differences (HCDiff) including chromosomal posi-
tions, sequence depths, variant’s allele frequencies and
SNP entry IDs. Comparison of the HCDiffs to HapMap
data allowed the evaluation of the SNV identification
accuracy, revealing a false-positive call rate of 2.3% per
site. With sensitivities and specificities of ≥94% for the
detection of heterozygote SNVs and >98% for homozy-
gote SNVs we achieve similar values to those obtained
by NimbleGen whole exome capture arrays combined
with Illumina sequencing [34].
The second filter step for the obtained HCDiffs used a
binomial distribution based model to distinguish with a
given probability between real SNVs and nucleotide dif-
ferences by PCR or sequencing errors. From the entire
set of HCDiffs for NA12716 and NA12760, 4.6% and
5.5% have a probability value P >10
-3, respectively.
There are, however, remarkable differences between the
excluded and remaining HCDiffs of the first filter step.
Of the discarded variations from the segmentally dupli-
cated region, 8.2% and 7.9% of the HCDiffs have P-
values > 10
-3 in contrast to 2.3% and 4.4% for the
retained ones. This suggests again that our filtering for
HCDiffs in the segmentally duplicated DEFB region is
reasonable.
With respect to the 4,184 SNVs identified in both
D N A sa n dt h ea p p l i e dq u a l i t yt h r e s h o l do fP≤ 10
-3 we
Table 3 DEFB cluster copy numbers (CN) per diploid
genome of NA12760 estimated by the ratio of reads per
haplotype
region/
gene
reads read numbers with
different haplotypes
read ratio CN
DEFB4 51 17:34 1:2 (3n) 6
89 16:62:11 1:4:1 6
down 45 10:26:9 1:3:1 5
stream 35 11:14:4:6 2:3:1:1 7
DEFB103 102 25:12:19:13:12:21 2:1:1:1:1:2 8
33 8:6:11:8 1:1:2:1 5
64 9:8:47 1:1:4 6
SPAG11 38 15:23 2:3 5
60 29:16:15 2:1:1 4
100 50:16:34 3:1:2 6
42 7:12:15:8 1:2:2:1 6
63 22:11:12:18 2:1:1:2 6
54 20:27:7 3:4:1 8
37 20:10:7 3:2:1 6
35 19:16 1:1 (2n) 6
48 14:21:13 2:3:2 7
30 4:21:5 1:5:1 7
32 8:14:10 2:3:2 7
48 7:22:19 1:3:3 7
48 9:20:6:13 1:2:1:1 5
62 13:18:13:7:11 2:2:2:1:1 8
34 6:13:15 1:2:3 6
33 12:21 1:2 (3n) 6
40 6:8:26 1:1:4 6
33 3:4:21:5 1:1:4:1 7
53 12:33:8 1:3:1 5
DEFB104 36 17:7:12 3:1:2 6
37 14:16:7 2:2:1 5
53 10:17:17:9 1:2:2:1 6
32 20:12 2:1 (3n) 6
30 13:10:7 3:2:1 6
30 14:6:6:4 3:1:1:1 6
86 63:26 3:1 4
62 6:8:21:27 1:1:3:3 8
65 13:23:15:14 1:2:1:1 5
31 6:6:6:5:8 1:1:1:1:2 6
38 10:10:5:3:10 2:2:1:1:2 8
29 6:7:16 1:1:3 5
31 9:14:8 2:3:2 7
33 6:27 1:5 6
DEFB106 100 32:12:18:38 2:1:1:2 6
77 21:13:31:12 2:1:3:1 7
30 8:22 1:3 (4n) 8
63 20:8:22:13 2:1:2:1 6
61 17:6:24:14 2:1:3:2 8
39 7:5:27 1:1:4 6
DEFB107 28 5:5:5:13 1:1:1:3 6
97 78:19 4:1 5
Table 3 DEFB cluster copy numbers (CN) per diploid gen-
ome of NA12760 estimated by the ratio of reads per
haplotype (Continued)
total number of
reads
2.397
total number of CN
estimations
48
CN per diploid
genome - average
6,17
- max 8
- min 4
- STDEV 1,06
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Page 8 of 13expect 4-5 false positives which are sequencing artifacts.
Under more stringent conditions (P ≤ 10
-4)w ew o u l d
exclude them which in turn remove another 97 poten-
tially real SNVs, thereof 25 (~7%) of the putative novel
variations (data not shown).
SNV densities and validation of putative novel SNVs
By our approach we identified 1,919 and 2,265 SNVs
(het and homvar) in the CTRL, DEFA and DEFB regions
for NA12716 and NA12760, respectively, corresponding
to a mean density of 2.3 and 2.7 SNV/kb (Table 2).
However, the SNV densities differ between the regions.
With 1.5 SNV/kb for both DNAs, the invariable single
copy CTRL genes have the lowest densities while they
are somewhat higher for the DEFA cluster with 3.2 and
2.4 SNV/kb for NA12716 and NA12760, respectively.
The highest density of 4.1 SNV/kb was observed for the
DEFB cluster of NA12716. In contrast, mapping the
identified DEFB SNVs of NA12760 to 3 DEFB copies
per haploid genome results in a density of 2.3 SNV/kb.
These findings reflect either a higher relatedness of
NA12760 DEFA/B to the reference sequence, or lower
sensitivity of the SNV detection in regions with high
CN, or both. Sensitivity problems are expected in parti-
cular for rare alleles in NA12760 DEFB (1:5) with an
expected VAF of 16.67% and an experimental VAF dis-
tribution between 10 and 25% which are selected against
by our stringent filtering (Figure 2).
In both DNA samples we have identified 358 putative
novel SNVs (Table 2, Figure 3). Their fraction with
respect to all identified SNVs ranges between 4% and
8% in the CTRL and DEFA regions but 15% and 17% in
DEFB. We compared our putative novel SNVs both
with the most current dbSNP132 database (release 2010,
September 23
rd)a n dt h ed a t af r o mt h e1 0 0 0G e n o m e s
Project (status 2011, January 18
th). The latter provided
sequences for NA12716 and NA12760 corresponding to
depths of ~8x and ~13x, respectively. Out of our 358
putative novel SNVs, 75 were meanwhile identified and
submitted to dbSNP by the 1000 Genomes Project and
another 93 by other groups. In contrast, 190 (53%) of
our novel SNVs identified by targeted analysis in just
Figure 4 SNVs in the putative DEFB4 promoter region ~1.9 kb upstream of the transcription start site inferred from the NA12716 and
NA12760 sequence alignments with variants’ allele frequencies (VAF) in comparison to the reference NCBI build 36.1 (hg18) and to
variations identified by Groth et al. [25]. Dash: homozygote for the hg18 allele NA12760 HTs: haplotypes from SNV combinations represented
by >30 sequences (+): confirmation of polymorphisms identified in [25]; for SNV details see additional file18. SNVs 252 and 260 (blue) were
found to be polymorphic in NA12716 and/or NA12760 by the present study but not in [25].
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Page 9 of 13two genomes remained undetected by the significantly
larger efforts of others. This underlines the efficiency of
our approach and is complemented by the fact that
namely in the DEFB cluster only 44 positions were gen-
otyped by HapMap [26].
There are no differences between known and putative
novel SNVs with respect to sequence depth and quality.
The mean sequence depth of the known SNVs is 59x
(CTRL 49x, DEFA 54x, DEFB 71x) and 58x for the
putative novel variations (CTRL 37x, DEFA 53x, DEFB
65x). For both known and putative novel SNVs more
than 97% of the variants have P-values <10
-4.
Out of the 2,886 SNVs identified in the two genomes,
48 are coding variations (34 non-synonymous, 14 synon-
ymous). Thereof, in the DEFB cluster, 5 SNVs (4 non-
synonymous, 1 synonymous) were found in the coding
sequences of DEFB104, DEFB106, DEFB105 and
DEFB107. None of these 5 SNVs are novel variations. In
contrast, 220 putative novel SNVs were identified in the
non-coding parts of the DEFB cluster. This indicates
that sequence divergence between DEFB cluster paralogs
rather evolves in non-coding than in protein-coding
regions and protein dosage is realized by different
expression levels of alleles. This is in accordance with
Hardwick et al. [23] showing that the different levels of
DEFB103 expression are not only the result of variable
gene copy numbers but also controlled by rapidly evol-
ving SNVs in regulatory regions.”
By PCR and Sanger sequencing we confirmed 95%
(21/22) of the putative novel SNVs. The unconfirmed
SNV which was found to be homozygote for the hg18
allele by Sanger sequencing, belongs to a group of 5 var-
iations with VAFs <25% in 454 sequencing. The VAF
for the not confirmed SNV (13%) is in the range for 1
deviating copy out of 6 (16.67%) indicating the difficulty
to distinguish between variations of this type and false
positives of the applied method. Candidate SNVs with
VAF ≥25% were all confirmed.
Although this study is focused on SNVs, polymorphic
insertions/deletions (indels) may cause particular pheno-
types and have to be assessed in future studies.
Haplotypes and copy numbers
With average sequence lengths between 300 and 350 bp
the obtained GS FLX sequences were suitable for the
identification of haplotypes in regions with a certain
SNV density. In total, 124 SNVs were informative for
the identification of 188 different haplotypes in the
DEFB regions of NA12716 and NA12760.
High sequencing depth and the calculation of read
ratios is essential for haplotype-based CN estimation. In
t h ep r e s e n tc a p t u r ee x p e r i m e n t ,t h es e q u e n c i n gd e p t h
was at the lower bound for a reliable CN determination.
In the case of NA12716, 11 informative SNV
combinations with an average of 31 reads per combina-
tion were available in DEFB. All of them exhibit 2 hap-
lotypes per locus, strongly supporting the DEFB number
of 2 per diploid genome as previously determined by
other methods [23,24]. In contrast, read ratios were con-
sistent with an expected 1:1 ratio of haplotypes only in 6
of the haplotyped regions. Nevertheless, artificially
improving sequencing depth by summing up read
counts for all loci resulted in a very robust haplotype
ratio of 0.99:1.00 (172/173).
For NA12760 with a higher DEFB CN of 6, the aver-
age number of sequences per SNV combination was
~50. Again, this is below the requirements for reliable
de novo CN estimation, in particular if the diplotype
comprises more than 2 copies. As consequence, DEFB
CN estimations for NA12760 by individual haplotype
regions ranged between 4 and 8. However, due to the
higher number of reads per haplotyped region, 48 CN
estimations were possible with an average ~6 copies per
diploid genome as previously determined by alternative
methods [7,23,24]. Since consistent CN estimations were
made from SNVs spread over the entire DEFB region
(DEFB4, DEFB103, SPAG11, DEFB104, DEFB106 and
DEFB107) our haplotyping results also confirm the con-
cordance of CNs for all genes within the cluster [35].
Completeness of SNV identification
In total, 82% of the CTRL, DEFA and DEFB target
regions were tiled by sequence capture probes in our
assay. The remaining untiled parts are located in repeti-
tive elements and/or regions with segmental duplica-
tions. Sequences and therefore HCDiffs from such
regions however can be obtained from enriched DNA
fragments captured by probes at the edges of non-repe-
titive/non-duplicated regions. Due to the uniqueness of
the fragment in its non-repetitive part, the HCDiffs out-
side of it should be correctly assigned to their chromo-
somal position and we regarded them as reliable
variations. Indeed, 510 (12%) out of 4,184 SNVs from
both DNAs are located within ± 200 bp around tiled
regions and 466 (91%) thereof are embedded in repeti-
tive elements.
While captured fragments extending the tiled regions
increase the fraction of sequence covered target parts, it
is decreased by ineffective probes. The probe efficiencies
are hard to estimate but are reflected by regions not or
poorly covered by 454 sequences despite being tiled. For
example, the mean sequence depth of the DEFA1A3
genes, spanning ~41 kb and located in the 178-kb-
DEFA cluster is underrepresented in both capture
experiments, with only 7x compared to 37x for the
entire cluster in NA12760.
Due to the described opposite effects and because the
true number of nucleotide differences between the
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Page 10 of 13target regions of the investigated DNAs and the hg18
reference is unknown, we cannot exactly quantify the
completeness of our SNV identification with respect to
the whole target regions. We can, however, give an esti-
mation based on the sequence depths. In the sequence
alignments of NA12716 and NA12760, 87% and 91% of
the target positions are covered by more than 5
sequences, respectively (data not shown). HCDiff identi-
fication by the Reference Mapper software is based on a
combination of flow signal and quality score and
requires a minimum number of sequences, the presence
of both forward and reverse reads covering the differ-
ence etc. The minimal requirement for classification of
a position as HCDiff is the coverage by ≥3 sequences in
both orientations with Phred quality ≥Q20 [36,37]
representing the variant, unless there are ≥5r e a d si n
just one orientation.
Therefore, as a conservative calculation, we estimate
the completeness of our SNV identification in NA12716
to less than ~87% with respect to the entire target
regions. Regarding the identified 1,919 SNVs this would
mean that we have missed at least ~290 SNVs, probably
located predominantly in repetitive regions.
With respect to the sensitivity of variation detection in
the CN variable DEFB, we can assume the same 98%
sensitivity for the tiled regions of the 2-copy sample
NA12716 as it is with one copy per haploid genome
genetically identical to the HapMap loci, from which the
sensitivity measure was derived. This high sensitivity/
specificity was achieved by eliminating all variations
with a VAF <25%. Of the final 673 NA12716 DEFB
SNVs only 7 (1%) show a VAF <25%. In contrast, 43%
(492/1157) of the NA12760 DEFB SNVs exhibit a VAF
<25%. These variations most likely are present in only
one of the 6 DEFB cluster copies. Moreover, these varia-
tions are heavily selected against by our stringent quality
filters (Figure 2). Thus, it has to be expected that the
sensitivity of our approach significantly drops in regions
with higher copy numbers. To estimate the sensitivity
for the 6-copy NA12760 DEFB, we assume 687 SNVs
(673 observed NA12716 SNVs divided by 0.98 sensitiv-
ity) per haploid DEFB. Thus we would expect in the
case of NA12760 a 3-times higher overall number of
2,061 DEFB SNVs. Having observed 1,157 NA12760
DEFB SNVs demonstrate a sensitivity of 56% in a 6-
copy case.
Mapping and analysis errors are another source of
missing variations. For our identifications we solely used
the high confidence differences (HCDiffs) extracted by
the Reference Mapper software (Roche). Sequence differ-
ences in the alignment not fulfilling these requirements
escape the SNV identification by our approach. In addi-
tion we observed a problem of the Reference Mapper
detecting HCDiffs when two differences between 454
read and reference appear at adjacent positions. For
example, SNV165 at chr8:7,277,507, used for haplotyping
in NA12716 is located beside another polymorphism
(SNV164, chr8:7,277,506) not identified as HCDiff (addi-
tional file 19). Although we expect only a minute portion
of differences missed by this shortcoming it may reduce
the completeness of SNV identification.
Conclusion
By NGS of target enriched DNAs, individual SNPs and
S N V sc a nb ea s s e s s e de v e ni nh i g h l yp o l y m o r p h i ca n d
CNV regions such as the human defensin gene locus.
SNV identification is highly specific and reveals a consid-
erable amount of putative novel individual polymorph-
isms. Furthermore it allows simultaneous CN estimations
by haplotyping. The sensitivity of the method is limited
by sequencing depth and stringency of data filtering.
Moreover, the observed lower sensitivity of the SNV
detection in samples with higher CN may reflect capture-
probe saturation and indicates the need for adjustment of
sequencing depth and CN. Despite the costs sequence
capture/NGS of copy number variable regions is a valu-
able source for identifying the growing number of causa-
tive variations for phenotypes/diseases.
Additional material
Additional file 1: Target regions, tiled (captured) regions and
chromosomal positions. Lengths, chromosomal positions and
description of the regions, targeted and tiled by Sequence Capture
Additional file 2: Results of sequencing and HCDiff identification.
454 sequences, target filtered sequences, sequence depths and HCDiff
numbers
Additional file 3: Verification of HCDiffs. Verification of HCDiffs from
NA12760 by PCR, direct sequencing and sequencing after cloning
Additional file 4: Categorization of HCDiffs by variant’s allele
frequency (VAF). Categorization of HCDiffs in the DEFA and CTRL
regions of NA12716 and NA12760 by variant’s allele frequency (VAF)
Additional file 5: Histogram of error densities. Histogram of error
densities
Additional file 6: Binomial simulation of allele calls from
heterozygous sites. The simulation accounts for the global error rate,
and the distribution of local sequence coverage is taken from the real
experiment
Additional file 7: Schematic view of the targeted regions DEFA and
DEFB (arrows) and their overlap to low copy repeats (LCRs)
according to the classification in Ref. [6]. LCR I contains successive
copies of the DEFA1/A3/T1 genes/pseudogenes and has no paralogs
elsewhere in the human genome. LCR V has two paralogs, representing
the two DEFB copies annotated in the hg18 reference genome. In
contrast, LCR IV has additional paralogs with up to 98% nucleotide
identity which are enriched together with the targeted DEFB cluster
hampering the SNV identification in the LCR IV region. Therefore, all
HCDiffs from the targeted part of the LCR IV region (~69 kb) were
discarded.
Additional file 8: Filtering of HCDiffs. Exclusion of 69-kb-segmentally
duplicated region, quality filtering following the binomial distribution
model, classification by region and variation type and overlap between
NA12716 and NA12760
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Page 11 of 13Additional file 9: Variant’s allele frequencies (VAF) before and after
filtering. Variant’s allele frequencies (VAF) for the CTRL+DEFA regions of
NA12760 before (1,180 HCDiffs) and after (1,108 SNVs) filtering
Additional file 10: HCDiffs identified from NA12716. HCDiffs
identified from NA12716 (CTRL, DEFA, DEFB, after exclusion of indels and
complex nucleotide exchanges)
Additional file 11: HCDiffs identified from NA12760. HCDiffs
identified from NA12760 (CTRL, DEFA, DEFB, after exclusion of indels and
complex nucleotide exchanges)
Additional file 12: SNVs identified from NA12716 and NA12760.
SNVs identified from NA12716 and NA12760 (CTRL, DEFA, DEFB), after
filtering of HCDiffs following workflow in Figure 1
Additional file 13: Verification of discrepancies Sequence Capture/
HapMap. PCR verification of 14 discrepancies Sequence Capture/
HapMap and 6 HapMap SNPs not identified by Sequence Capture
Additional file 14: Haplotyping candidate regions (HTCR).
Haplotyping candidate regions (HTCR) with high density of polymorphic
positions used for haplotyping
Additional file 15: SNVs used for haplotyping within HTCRs. List of
all SNVs within the HTCRs which were used for haplotyping and CN
estimation illustrated in additional file 14
Additional file 16: DEFB haplotype inference and CN estimation.C N
estimation by calculation of the ratios of reads representing the different
haplotypes within the HTCRs
Additional file 17: SNVs in the DEFB4 promoter region. SNVs in the
DEFB4 promoter region in comparison to previous data published in Ref.
[25]
Additional file 18: DEFB4 Promoter region haplotype inference and
CN estimation (NA12760). Haplotype calls (HC) and CN estimation
based on distal cluster for NA12760/DEFB4 Promoter region (threshold:
≥30 reads)
Additional file 19: Adjacent polymorphisms of which only one is
identified by runAssembly. SNV165 at chr8:7,277,507, used for
haplotyping in NA12716 is located beside another polymorphism
(SNV164, chr8:7,277,506) not identified as HCDiff by the runAssembly
software.
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